LptD-antigen system on gold nanoparticles: an innovative strategy in the nanovaccine development.

Nanovaccine development is a growing research field in which the development of new carriers and bioconjugation approaches is a priority. In this sense, this report describes for the first time, the development of a novel conjugate that consists of gold nanoparticles (AuNPs) obtained by a one-step synthesis using an immunogenic peptide of the Lipopolysaccharide-assembly protein LptD frombacteria as a reducing and capping agent. The resultingcompounds were fully characterized and the results showed the high capacity of the peptide to form complexes and reduce gold ions.